Advances in the management of pancreatic ductal adenocarcinoma

被引：13
|
作者：
O'Kane, Grainne M. [1 ]
Ladak, Farah [2 ]
Gallinger, Steven [1 ]
机构：
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Alberta, Edmonton, AB, Canada
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2021年 / 193卷 / 23期
关键词：
PHASE-II; ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; CANCER RISK; GEMCITABINE; CHEMORADIOTHERAPY; SUBTYPES; SURVIVAL; THERAPY; REARRANGEMENTS;
D O I：
10.1503/cmaj.201450
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E844 / E851
页数：8
相关论文
共 50 条
  • [21] Pharmacological Ascorbate Enhances Chemotherapies in Pancreatic Ductal Adenocarcinoma
    O'Leary, Brianne R.
    Ruppenkamp, Elena K.
    Steers, Garett J.
    Du, Juan
    Carroll, Rory S.
    Wagner, Brett A.
    Buettner, Garry R.
    Cullen, Joseph J.
    PANCREAS, 2022, 51 (06) : 684 - 693
  • [22] Multidisciplinary management of locally advanced pancreatic ductal adenocarcinoma
    Alemi, Farzad
    Alseidi, Adnan
    Helton, W. Scott
    Rocha, Flavio G.
    CURRENT PROBLEMS IN SURGERY, 2015, 52 (09) : 362 - 398
  • [23] Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma
    Yanagimoto, Hiroaki
    Satoi, Sohei
    Yamamoto, Tomohisa
    Yamaki, So
    Hirooka, Satoshi
    Kotsuka, Masaya
    Ryota, Hironori
    Ishida, Mitsuaki
    Matsui, Yoichi
    Sekimoto, Mitsugu
    CANCERS, 2020, 12 (06)
  • [24] Management of Peritoneal Metastasis in Patients with Pancreatic Ductal Adenocarcinoma
    Wu, Grace
    Standring, Oliver J.
    King, Daniel A.
    Gholami, Sepideh
    Devoe, Craig E.
    Thiels, Cornelius A.
    Grotz, Travis E.
    Weiss, Matthew J.
    Whelan, Richard L.
    Raoof, Mustafa
    Deperalta, Danielle K.
    CURRENT ONCOLOGY, 2025, 32 (02)
  • [25] Metabolomic prediction of treatment outcome in pancreatic ductal adenocarcinoma patients receiving gemcitabine
    Phua, Lee Cheng
    Goh, Shixu
    Tai, David Wai Meng
    Leow, Wei Qiang
    Alkaff, Syed Muhammad Fahmy
    Chan, Chung Yip
    Kam, Juinn Huar
    Lim, Tony Kiat Hon
    Chan, Eric Chun Yong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (02) : 277 - 289
  • [26] Adjuvant Treatment of Surgically Resectable Pancreatic Ductal Adenocarcinoma
    Tesfaye, Anteneh A.
    Philip, Philip A.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (01) : 54 - 63
  • [27] Sex-Related Differences in Pancreatic Ductal Adenocarcinoma Progression and Response to Therapy
    Grahovac, Jelena
    Duric, Ana
    Tanic, Miljana
    Krivokuca, Ana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (23)
  • [28] Review of Current Systemic Therapy and Novel Systemic Therapy for Pancreatic Ductal Adenocarcinoma
    Sarfraz, Humaira
    Saha, Aditi
    Jhaveri, Khushali
    Kim, Dae Won
    CURRENT ONCOLOGY, 2023, 30 (06) : 5322 - 5336
  • [29] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
    Alvarez, R.
    Ales, I.
    Diaz, R.
    de Paredes, B. G.
    Hidalgo, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (10) : 1193 - 1198
  • [30] Surgery for recurrent pancreatic ductal adenocarcinoma
    Kleeff, Joerg
    Reiser, Carolin
    Hinz, Ulf
    Bachmann, Jeannine
    Debus, Jurgen
    Jaeger, Dirk
    Friess, Helmut
    Buechler, Markus W.
    ANNALS OF SURGERY, 2007, 245 (04) : 566 - 572
12345